Medical Innovation Exchange

ESMO: Regeneron's plans to take on ovarian cancer with bispecifics boosted with new CD3 data

https://www.fiercebiotech.com/biotech/esmo-regeneron-plans-take-ovarian-cancer-new-data-providing-boost

Leave a Comment

Your email address will not be published.

Leave the field below empty!